Gamida Cell Ltd.
GMDADelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001600847
Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Gamida Cell Ltd. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 60 | 52 | −8 |
| Shares | 34.5M | 31.9M | −2.55M (−7.4%) |
| Value | $35.3M | $13.2M | −$22.1M (−62.7%) |
New holders (5)
Institutions that held Gamida Cell Ltd. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 2,568,866 | $1.06M | 0.00% |
| Renaissance Technologies LLC | 957,581 | $395.0K | 0.00% |
| Squarepoint Ops LLC | 542,741 | $224.0K | 0.00% |
| Jane Street Group, LLC | 19,333 | $7.98K | 0.00% |
| O'Dell Group, LLC | 400 | $166 | 0.00% |
Sold out (13)
Institutions that held Gamida Cell Ltd. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Stonepine Capital Management, LLC | 7,965,865 | $8.20M |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $175.5K |
| Sabby Management, LLC | 111,264 | $114.6K |
| Rock Springs Capital Management LP | 52,015 | $53.6K |
| XTX Topco Ltd | 30,203 | $31.1K |
| Simplex Trading, LLC | 27,860 | $28.0K |
| Credit Suisse AG | 27,000 | $27.8K |
| Marshall Wace, LLP | 18,761 | $19.3K |
| HBK Sorce Advisory LLC | 18,370 | $18.9K |
| Sandhill Capital Partners LLC | 14,244 | $14.7K |
| Victory Capital Management Inc | 10,950 | $11.3K |
| Harel Insurance Investments & Financial Services Ltd. | 1,822 | $2.00K |
| US Bancorp | 800 | $824 |